The recent global pandemic of COVID-19 has predisposed a relatively high number of
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …

As a novel risk factor, COVID-19 has led to an increase in the incidence of candidemia and
an elevated mortality rate. Despite being of clinical importance, there is a lack of data …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …

The incidence of COVID-19-associated candidiasis (CAC) is increasing, resulting in a grave
outcome among hospitalized patients with COVID-19. The most alarming condition is the …

Infection with SARS-CoV-2 can lead to Coronavirus disease-2019 (COVID-19) and result in
severe acute respiratory distress syndrome (ARDS). Recent reports indicate an increased …

We have read with interest the article by Lewis White and Colleagues, providing insights on
invasive fungal infections in COVID-19 patients [1]. The Authors describe a significant …

Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

(COVID-19) patients [1]. The authors describe a significant proportion of invasive yeast
infections, especially candidemia. To date, it is not clear if the incidence of candidemia in …

Background The COVID-19 pandemic has resulted in unprecedented healthcare
challenges, and COVID-19 has been linked to secondary infections. Candidemia, a fungal …

Patients presenting with severe COVID-19 are predisposed to acquire secondary fungal
infections such as COVID-19-associated candidemia (CAC), which are associated with poor …